METHODS: We conducted a MEDLINE search (to 30 September 2015) of GSH use for skin lightening and of all indications in medicine, to evaluate its safety
Novo touted cagrilintide as being well-tolerated, with just 1% of patients who received the drug discontinuing, compared to 0.1% in the placebo arm
You must not copy any of the materials
As more patients turn to injectable peptides like BPC-157, CJC-1295, Tesamorelin, and MOTS-c, it's important to understand what happens beneath the skin after the needle goes in
Study design should follow the specific research question, and researchers should consult current literature and institutional protocols before combining any research peptides
DOI: 10.1007/s00441-019-03016-8